-
- 抗原 See all CD55 抗体
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CD55 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Flow Cytometry (FACS), Immunoprecipitation (IP), Functional Studies (Func)
- 产品特性
- Purified IgG
- 纯化方法
- Purified
- 免疫原
- Human fibroblast cell line
- 克隆位点
- BRIC216
- 亚型
- IgG1
- Top Product
- Discover our top product CD55 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1.0 mg/mL
-
-
Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, (2006) (PubMed).
: "Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome." in: Molecular immunology, Vol. 44, Issue 7, pp. 1559-68, (2006) (PubMed).
: "
-
Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, (2006) (PubMed).
-
- 抗原
- CD55 (Complement Decay-Accelerating Factor (CD55))
- 别名
- CD55 (CD55 产品)
- 背景
- Synonyms: DAF
- 基因ID
- 1604
- UniProt
- P08174
- 途径
- Complement System, Regulation of Leukocyte Mediated Immunity
-